Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Clinical trial NCT06374043 · COMPLETED

Trial details

NCT number: NCT06374043
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Diabetes Mellitus Type 2 With Proteinuria Diabetes Mellitus Diabetes Diabetes Complications Albuminuria Chronic Kidney Diseases Chronic Kidney Disease Due to Type 2 Diabetes Mellitus CKD Proteinuria

Start date: 2021-05-11
Primary completion: 2022-09-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.